New Orleans, LA, United States of America

Min Li

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Gretna, LA (US) (2015)
  • New Orleans, LA (US) (2014 - 2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Min Li: Innovator in Kidney Treatment

Introduction

Min Li is a notable inventor based in New Orleans, LA (US), recognized for his contributions to medical science, particularly in the treatment of kidney-related conditions. He holds a total of 3 patents, showcasing his innovative approach to healthcare.

Latest Patents

One of Min Li's latest patents focuses on the use of pituitary adenylate cyclase-activating polypeptide (PACAP) and its analogs for treating contrast-induced nephropathy. This invention features methods and compositions aimed at treating, managing, preventing, or reducing kidney injury caused by iodinated radiocontrast media. The methods involve administering effective amounts of PACAP-like compounds, including native human PACAP38, native human PACAP27, and vasoactive intestinal peptide (VIP), along with their agonists, analogs, fragments, and derivatives. Additionally, the patent provides pharmaceutical compositions that can be used in conjunction with other therapeutic agents to protect the kidneys during treatment with iodinated radiocontrast media. Another significant patent addresses the treatment of renal dysfunction and multiple myeloma using PACAP compounds. This invention outlines methods for managing these conditions through the administration of PACAP compounds, which include PACAP and VIP, along with their derivatives.

Career Highlights

Min Li has made significant strides in his career, particularly through his work with The Administrators of the Tulane Educational Fund and The Administrators of Tulane. His research and innovations have contributed to advancements in medical treatments, particularly in nephrology.

Collaborations

Min Li has collaborated with notable colleagues, including David H. Coy and Jerome L. Maderdrut. Their combined expertise has furthered the development of innovative treatments in the medical field.

Conclusion

Min Li's work exemplifies the impact of innovation in healthcare, particularly in the treatment of kidney-related conditions. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…